Rise In Securities Class Action Filings In Life Sciences Sector
Executive Summary
Last year proved to be another record period for securities class actions, with a 13% increase in cases filed compared with 2018, and a 24% increase in claims brought against life sciences companies compared with 2018, according to a report by Cornerstone Research: Securities Class Action Filings: 2019 Year In Review.
You may also be interested in...
South Korea Implements IVD Regulation Amid Renewed COVID-19 Scare
South Korea, one of the first countries to be hit by the spread of COVID-19 from China, has implemented new standalone IVD regulations.
China's New Hong Kong Security Law To Derail Biotech IPOs?
A new national security law passed by China is expected to bring an uncertain future to many health companies eyeing a possible listing in Hong Kong.
Gerolymatos Inks Deal With Gifrer For France
Gerolymatos International's Sinomarin seawater-based nasal spray is now distributed in France by Laboratoire Gifrer.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports